Literature DB >> 20123

The assessment of beta-adrenoceptor blocking drugs in man.

D G McDevitt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 20123      PMCID: PMC1429044          DOI: 10.1111/j.1365-2125.1977.tb00756.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  58 in total

1.  Plasma concentrations and the time-course of beta blockade due to propranolol.

Authors:  D G McDevitt; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1975-12       Impact factor: 6.875

2.  Problems in assessing beta-adrenoceptor antagonism in man.

Authors:  C F George
Journal:  Br J Clin Pharmacol       Date:  1975-02       Impact factor: 4.335

3.  THE CIRCULATIORY EFFECTS OF SUSTAINED VOLUNTARY MUSCLE CONTRACTION.

Authors:  A R LIND; S H TAYLOR; P W HUMPHREYS; B M KENNELLY; K W DONALD
Journal:  Clin Sci       Date:  1964-10       Impact factor: 6.124

4.  A COMPARISON OF THE EFFECTS OF ISOPROTERENOL IN THE NORMAL AND ASTHMATIC SUBJECT. A PRELIMINARY REPORT.

Authors:  D U COOKSON; C E REED
Journal:  Am Rev Respir Dis       Date:  1963-11

5.  Blocking of inhibitory adrenergic receptors by a dichloro analog of isoproterenol.

Authors:  C E POWELL; I H SLATER
Journal:  J Pharmacol Exp Ther       Date:  1958-04       Impact factor: 4.030

6.  Effects of atropine on heart rate and oxygen intake in working man.

Authors:  S ROBINSON; M PEARCY; F R BRUECKMAN; J R NICHOLAS; D I MILLER
Journal:  J Appl Physiol       Date:  1953-03       Impact factor: 3.531

7.  Plasma levels and beta-adrenoceptor blockade with acebutolol, practolol and propranolol in man.

Authors:  M F Cuthbert; R F Collins
Journal:  Br J Clin Pharmacol       Date:  1975-02       Impact factor: 4.335

8.  Effects of intravenous propranolol and metoprolol and their interaction with isoprenaline on pulmonary function, heart rate and blood pressure in asthmatics.

Authors:  G Johnsson; N Svedmyr; G Thiringer
Journal:  Eur J Clin Pharmacol       Date:  1975-04-04       Impact factor: 2.953

9.  Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker.

Authors:  H C Brown; S G Carruthers; G D Johnston; J G Kelly; J McAinsh; D G McDevitt; R G Shanks
Journal:  Clin Pharmacol Ther       Date:  1976-11       Impact factor: 6.875

10.  Isoproterenol sensitivity and total body clearance of propranolol in hypertensive patients.

Authors:  G M London; M E Safar; Y A Weiss; P L Milliez
Journal:  J Clin Pharmacol       Date:  1976-04       Impact factor: 3.126

View more
  67 in total

1.  Selectivity of antagonist and partial agonist activity of celiprolol in normal subjects.

Authors:  N M Wheeldon; D G McDevitt; B J Lipworth
Journal:  Br J Clin Pharmacol       Date:  1992-10       Impact factor: 4.335

2.  Differential cardiovascular effects of propranolol, atenolol, and pindolol measured by impedance cardiography.

Authors:  S H Thomas; R C Cooper; M Ekwuru; S Fletcher; J Gilbody; T S Husseyin; M Ishaque; R Jagathesan; G Reddy; S E Smith
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 3.  The applied pharmacology of beta-adrenoceptor antagonists (beta blockers) in relation to clinical outcomes.

Authors:  J D Fitzgerald
Journal:  Cardiovasc Drugs Ther       Date:  1991-06       Impact factor: 3.727

4.  A dose-ranging study to evaluate the beta 1-adrenoceptor selectivity of bisoprolol.

Authors:  B J Lipworth; N A Irvine; D G McDevitt
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

5.  The effects of chronic dosing on the beta 1 and beta 2-adrenoceptor antagonism of betaxolol and atenolol.

Authors:  B J Lipworth; N A Irvine; D G McDevitt
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

6.  Effects of the beta 2-adrenoceptor antagonist ICI 118,551 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.

Authors:  J M Arnold; P C O'Connor; J G Riddell; D W Harron; R G Shanks; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1985-05       Impact factor: 4.335

7.  Comparison of the haemodynamic effects of bucindolol, propranolol and pindolol in healthy volunteers.

Authors:  P C O'Connor; M J Finch; D W Harron; P A Meredith; D G McDevitt; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1985-12       Impact factor: 4.335

8.  An assessment of beta-adrenoceptor blockade in man by prizidilol hydrochloride.

Authors:  D W Pitcher; P V Curry; J R Trounce
Journal:  Br J Clin Pharmacol       Date:  1982-05       Impact factor: 4.335

9.  Asthma and beta-blockers.

Authors:  D S Lawrence; J N Sahay; S S Chatterjee; J M Cruickshank
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

10.  Comparison of four different beta-adrenoceptor blocking drugs on lymphocyte isoprenaline-stimulated cyclic AMP production.

Authors:  D R Lima; S Kilfeather; A Hedges; P Turner
Journal:  Br J Clin Pharmacol       Date:  1981-06       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.